Advair News & Warnings

GlaxoSmithKline recently agreed to new blackbox warnings for Advair and Serevent. Recently it has been found that Advair may increase the risk of asthma-related death. Below are breaking news stories involving Advair.

GlaxoSmithKline reaches agreement to update product label

April 7th, 2006 (newkerala.com)

"[S]almeterol] one of the active ingredients in ADVAIR DISKUS may increase the risk of asthma-related death. Therefore, when treating patients with asthma, physicians should only prescribe ADVAIR DISKUS for patients not adequately controlled on other asthma controller medications or whose disease severity clearly warrants initiation of treatments with two maintenance therapies," the new label said.

Death Risk Warning for Asthma Drugs

March 08, 2006 (foxnews.com)

GlaxoSmithKline, which makes both Advair and Serevent, agreed to the new ‘black box’ warnings -- the strongest warning a drug label can carry. The agreement follows the FDA's November 2005 request for an update of the drugs' existing black box labels.

Weitz & Luxenberg is no longer accepting new Advair cases.

see also:

Advair Black Box Warning Advair Warnings: FDA Warning Advair: Advair Black Box Warning
Warning! Advair Black Box FDA Warning for Dangerous Asthma Drug

News & Warnings Advair Lawsuit - Advair Breaking News & Warnings
Keep up to date with Advair with Breaking Advair News & Warnings

Research Center Advair Research Center- Research Advair Dangers from Advair Law Firm
Advair Asthma Drug Research - Learn about Adviar & Advair Lawsuits